3 results for author:"Ni I." in Literature citations
Results Customize
› Repeat search in UniProtKB (54)
| Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Lee L.F., Logronio K., Tu G.H., Zhai W., Ni I., Mei L., Dilley J., Yu J., Rajpal A., Brown C. et al. Proc. Natl. Acad. Sci. U.S.A. 109:12674-12679(2012) · Mapped (5) |
| The B56gamma3 regulatory subunit of protein phosphatase 2A (PP2A) regulates S phase-specific nuclear accumulation of PP2A and the G1 to S transition. Lee T.Y., Lai T.Y., Lin S.C., Wu C.W., Ni I.F., Yang Y.S., Hung L.Y., Law B.K., Chiang C.W. J. Biol. Chem. 285:21567-21580(2010) · Mapped (8) |
| Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M. Arthritis Res. Ther. 10:R73-R73(2008) · UniProtKB (54) |